[ Price : $8.95]
Boston Scientific recalls (Class 1) its Obsidio Conformable Embolic device to update the use instructions due to a concern about r...[ Price : $8.95]
GE Healthcare recalls its Giraffe OmniBed neo-natal incubator after receiving reports about the screw that secures the door becomi...[ Price : $8.95]
FDA issues a partial clinical hold on a BioNTech and OncoC4, Phase 3 trial that is assessing gotistobart in non-small cell lung ca...[ Price : $8.95]
FDA publishes a guidance outlining a framework for considering the types of long-term neurodevelopmental safety studies that could...[ Price : $8.95]
FDA says it is continuing to review the sNDA submitted by Intercept Pharmaceuticals for its Ocaliva following an advisory committe...[ Price : $8.95]
FDA approves an AbbVie NDA for Vyalev (foscarbidopa and foslevodopa), a subcutaneous 24-hour infusion of levodopa-based therapy fo...[ Price : $8.95]
FDA posts a draft guidance entitled Postoperative Nausea and Vomiting: Developing Drugs for Prevention.[ Price : $8.95]
Federal Register notice: FDA extends the comment period on a 9/23 notice about three draft guidance documents related to CDRHs Acc...